Mirdametinib Monotherapy in Adults With Neurofibromatosis 1 (NF1) and Cutaneous Neurofibromas (cNF). (Mirda)

syn53480723

Created By NF Service nf-osi-service

studyName: Mirdametinib Monotherapy in Adults With Neurofibromatosis 1 (NF1) and Cutaneous Neurofibromas (cNF). (Mirda)
dataStatus: Data Pending
initiative: Clinical Research Award
studyLeads: Carlos Romo
studyStatus: Active
diseaseFocus: Neurofibromatosis type 1
institutions: Johns Hopkins University
fundingAgency: NTAP
manifestation: Cutaneous Neurofibroma
studyFileviewId: syn53480729
syn53480724
syn53480747
syn53480725
syn53480729
syn53480726

Your web browser must have JavaScript enabled in order for this application to display correctly.
If you are an automated web crawler from a search engine, follow this AJAX application crawl link

Mirdametinib Monotherapy in Adults With Neurofibromatosis 1 (NF1) and Cutaneous Neurofibromas (cNF). (Mirda)

syn53480723

Drop files to upload

Mirdametinib Monotherapy in Adults With Neurofibromatosis 1 (NF1) and Cutaneous Neurofibromas (cNF). (Mirda) page is loading…